Your browser does not support javascript

Investors

QwikReport

Go to Bottom of PageGo to Next SectionCategoryGo to Prevous SectionGo to Top of Page
(untitled) (2 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionCold and FluGo to Prevous SectionGo to Top of Page
DefenZall (1 KB)
DefenZall Daily (2 KB)
DefenZall Nasal Spray (1 KB)
All of the items listed above (4 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionCognitiveGo to Prevous SectionGo to Top of Page
Migraine (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionAnti-InflamatoryGo to Prevous SectionGo to Top of Page
AstaXanthin (2 KB)
Krill Oil (2 KB)
All of the items listed above (3 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionWomen's HealthGo to Prevous SectionGo to Top of Page
Osteoporosis bone health (3 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionNutrition SupplementationGo to Prevous SectionGo to Top of Page
Proteins (1 KB)
Growth Plus (1 KB)
All of the items listed above (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionInvestorsGo to Prevous SectionGo to Top of Page
(untitled) (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionNewsGo to Prevous SectionGo to Top of Page
February 21, 2012
Abattis Announces a Binding Letter Agreement with Animo Wellness Corporation (3 KB)
February 17, 2012
Abattis Announces Cancellation of 10,250,000 Shares Pursuant to Termination of ZITEK Licensing Agreement (2 KB)
February 16, 2012
Abattis to sponsor and present in the 20th Annual Wellness Show and the launch of the worlds first painless Flu shot (5 KB)
February 15, 2012
Abattis Closes Second Tranche of Private Placement (2 KB)
February 06, 2012
Abattis Announces Grant of Stock Options and Shares for Debt Settlement (2 KB)
All of the items listed above For brevity only the 5 most recent items are listed. (16 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionStock InfoGo to Prevous SectionGo to Top of Page
Stock Chart Link (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionIn the MediaGo to Prevous SectionGo to Top of Page
February 10, 2012
Market backs transformational Vernalis deal (1 KB)
June 09, 2011
New flu virus emerges after child co-infected with H1N1, H3N2; vaccine protective (1 KB)
May 17, 2011
Gates says vaccine investment offers best returns (1 KB)
May 17, 2011
Natural Cold and Flu Remedies (1 KB)
Big Pharma Backs Deal to Boost Flu Pandemic Readiness (1 KB)
All of the items listed above (4 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionManagementGo to Prevous SectionGo to Top of Page
President & CEO
Mike Withrow 		Chief Science and Medical Advisory
Dr. Samuel Brant LLC.
PhD, Director & Global Product Development Advisor
Tim Fealey 		Investor Relations
Hamza Thindal Capital Corporation
All of the items listed above (4 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionDirectors & OfficersGo to Prevous SectionGo to Top of Page
Director
Mr. Mike Withrow 		Director
Tim Fealey, PhD
Director
Mr. Douglas Sorocco, LLb 		Advisor to the Board
Phil Hardy, Ph.D.
B, Com
Yazan Al Homsi 		  
All of the items listed above (8 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionMissionGo to Prevous SectionGo to Top of Page
Mission and Objectives (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionHistoryGo to Prevous SectionGo to Top of Page
(untitled) (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionSocial ResponsibilityGo to Prevous SectionGo to Top of Page
(untitled) (1 KB)
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionOfficesGo to Prevous SectionGo to Top of Page
Corporate Headquarters
Abattis Biologix Corporation
Show printable version of these items in a Popup Window Click printer Icon for a printable version of the above items.

Go to Bottom of PageGo to Next SectionSelect Your QwikReportGo to Prevous SectionGo to Top of Page
Show a report based on your selections in this window.
Show a printable version of your report in a new window.
Reset all the selections above.

 

Follow Us:

Copyright © 2011 Abattis Biologix Corporation